Skip to main content
Diabetes Type 1 Diabetes

Type 1 Diabetes

Open Access Type 1 Diabetes Case Study

Managing exogenous insulin antibody syndrome

EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.

Editor's Choice

The promise of once-weekly insulins

Open Access Insulins Review

Once-weekly insulins offer a way to simplify therapy and reduce the treatment burden for people with type 2 diabetes, and also have potential for individuals with type 1 diabetes.

Lower heritability of adult-onset versus childhood-onset type 1 diabetes

23-04-2024 Type 1 Diabetes News

Type 1 diabetes that develops in adulthood has weaker familial associations than type 1 diabetes that develops in childhood.

Discussing the IWGDF guideline on offloading treatments for diabetes-related foot ulcers

Open Access Diabetic Foot Podcast

In this Adis podcast, the guideline’s lead authors highlight why offloading treatments are needed, what the updated guideline recommends, and what the offloading future could bring.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu

Case Studies

Managing exogenous insulin antibody syndrome

Open Access Type 1 Diabetes Case Study

EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.

ICI-induced insulin-dependent diabetes without islet autoantibodies

Diabetes Case Study

Rapidly progressive insulin-dependent diabetes in the absence of islet autoantibodies developed 2 years after starting treatment with the immune checkpoint inhibitor nivolumab.

Type 1 diabetes after COVID-19 vaccination

This case report considers two cases of type 1 diabetes diagnosed after multiple COVID-19 vaccinations. HLA haplotypes associated with susceptibility to type 1 diabetes were present in both cases.

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by: Abbott Diabetes Care

Prof. Samuel Seidu
Developed by: Adis

Current Reviews

Vitamin D efficacy in type 1 and type 2 diabetes

Type 1 Diabetes Invited Review

It is well known that vitamin D has a profound effect on calcium and bone metabolism, but its influence on other organs (extraskeletal effect) has been proposed. Consistently, vitamin D deficiency is associated with an increased incidence of …

Cross-sectional imaging of the pancreas in diabetes

Diabetes mellitus presents a global health challenge characterized by dysregulated glucose metabolism and insulin resistance. Pancreas dysfunction contributes to the development and progression of diabetes. Cross-sectional imaging modalities have …

Advances in clinical research on glucagon

Type 1 Diabetes Mini-Review

We are now celebrating the 100th anniversary of the discovery of an important pancreatic hormone, glucagon. Glucagon is historically described as a diabetogenic hormone elevating glucose levels via increases in insulin resistance and hepatic …

Diagnosing Osteoporosis in Diabetes—A Systematic Review on BMD and Fractures

Type 2 diabetes (T2D) and osteoporosis are two common and chronic diseases in the elderly population. The increased risk of fractures in subjects with type 1 diabetes (T1D) and T2D has been investigated for more than 30 years [ 1 ]. It is well …

Insulins Clinical Trial Summary

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.

Developed by: Springer Medicine

Tweetorials | Vodcasts | Infographics (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME
Webinar | 08-11-2023 | 18:00 (CET)

Keynote webinar | Spotlight on diet and diabetes

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

Prof. Mike Lean
Prof. Falko Sniehotta
Developed by: Springer Medicine

Further Reading

An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy

Open Access Type 1 Diabetes Original Research

Diabetes is a complex metabolic disorder with a higher risk of microvascular or macrovascular complications compared to the general population, which is associated with increased mortality [ 1 , 2 ]. In high-income countries, diabetes is one of the …

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Open Access Type 1 Diabetes Original Research

Glucose control is key to preventing diabetes complications in people with type 1 diabetes [ 1 – 4 ]. Analyses of glucose levels related to lower risk of diabetes complications have generally been based on the biomarker HbA 1c [ 2 ]. HbA 1c does …

The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes

Open Access Type 1 Diabetes Original Research

Exercise provides health benefits for individuals with type 1 diabetes, through reducing CVD, improving skeletal muscle health and increasing fitness [ 1 , 2 ]. Despite the benefits of exercise, barriers to its use as a diabetes therapy remain.

The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes

Open Access Type 1 Diabetes Research

The study was carried out to determine the psychosocial outcomes of advanced hybrid closed-loop (AHCL) systems in children and adolescents with type 1 diabetes (T1D). Single-center and cohort study with a duration 6 months consisted of 60 children …